3,883
edits
Changes
no edit summary
#Pages in need of authors can be found here: <u>[[Volunteer Assignments and Opportunities]]</u> (''see “Authors” column and look for any that are not assigned''; every attempt is made to keep this updated).
#Pages in need of authors can be found here: <u>[[Volunteer Assignments and Opportunities]]</u> (''see “Authors” column and look for any that are not assigned''; every attempt is made to keep this updated).
#We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books. Therefore, if there is an entity not yet listed that you would like to author, we would be happy to create a page for you now.
#We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books. Therefore, if there is an entity not yet listed that you would like to author, we would be happy to create a page for you now.
#For diseases that are present in multiple WHO books, our goal is to have a main page for a disease entity from one book (which book is selected based on being the most relevant), and then the pages for the same entity in other books would refer to that page plus have their book-specific (''i.e.,'' body site) content. It is appreciated if the same author could volunteer for the related pages.
#For diseases that are present in multiple WHO books, our goal is to have a main page for a disease entity from one book (the primary book is selected based on being the most relevant), and then the pages for the same entity in other books would refer to that page plus have their book-specific (''i.e.,'' body site) content. It is appreciated if the same author could volunteer for the related pages.
*For pages that do not yet have any content, authors will be connected by the Editor-in-Chief with an Associate Editor based on their disease section(s) of interest.
*For pages that do not yet have any content, authors will be connected by the Editor-in-Chief with an Associate Editor based on their disease section(s) of interest.
*Authors will be given a username and password by the Technical Associate Editor after they complete the [https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>].
*Authors will be given a username and password by the Technical Associate Editor after they complete the [https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>].
<br />
<br />
*Pages are based on current WHO entries and contain pre-loaded templates (of note, if there’s a non-WHO entity of importance, a new page can be created). Authors can work directly on the CCGA site or use a Word template (see section below to download; please track references by PMIDs as the site allows for automatic input of references based on PMIDs) and then copy/paste the content into the wiki site.
*Pages are based on current WHO entries and contain pre-loaded templates. Authors can work directly on the CCGA site. Authors can instead use a Word template (see section below to download; please track references by PMIDs as the site allows for automatic input of references based on PMIDs) and then copy/paste the content into the wiki site.
*There are two types of pages currently needing authors:
*There are two types of pages currently needing authors:
*For more details on how you use the site to be an author, please watch an instructional video (see section below).
*For more details on how you use the site to be an author, please watch an instructional video (see section below).
*Content inclusion details:
*Content inclusion details:
**Populate all the tables (i.e. for immunophenotype, chromosomal rearrangements, genomic gain/loss/LOH, etc) when applicable (DO NOT delete tables).
**Populate all the tables (''i.e.,'' for immunophenotype, chromosomal rearrangements, genomic gain/loss/LOH, etc) when applicable (DO NOT delete tables).
**Insert N/A into sections or tables when there is not applicable content; for tables, delete the examples.
**Insert N/A into sections or tables when there is not applicable content; for tables, delete the examples.
**Use [https://www.genenames.org/ HUGO-approved gene names and symbols] (italicized when appropriate), [https://varnomen.hgvs.org/ HGVS-based nomenclature for variants], as well as generic names of drugs and testing platforms or assays if applicable
**Use [https://www.genenames.org/ HUGO-approved gene names and symbols] (italicized when appropriate), [https://varnomen.hgvs.org/ HGVS-based nomenclature for variants], as well as generic names of drugs and testing platforms or assays if applicable